Viable tumor tissue detection in murine metastatic breast cancer by whole-body MRI and multispectral analysis

Magnetic Resonance in Medicine

Volumn 62, Issue 6, 2009, Pages 1423-1430

  Barck, Kai H ^a   Willis, Brandon ^a   Ross, Jed ^a   French, Dorothy M ^a   Filvaroff, Ellen H ^a   Carano, Richard A D ^a  

^a GENENTECH INC   (United States)

Author keywords

Diffusion; Metastasis; Multispectral analysis; Splenic extramedullary hematopoiesis; Tumor; Whole body

Indexed keywords

CELL CULTURE; DIAGNOSIS; DIFFUSION; DISEASES; IMAGE SEGMENTATION; K-MEANS CLUSTERING; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; PATHOLOGY; SURFACE DIFFUSION; TUMORS;

APPARENT DIFFUSION COEFFICIENT; METASTASIS; MORPHOLOGIC OPERATIONS; MULTI-SPECTRAL ANALYSIS; MULTI-SPECTRAL IMAGE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC CURVES; SPLENIC EXTRAMEDULLARY HEMATOPOIESIS; WHOLE BODY;

TISSUE ENGINEERING;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; HISTOLOGY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY TUMOR; TUMOR NECROSIS; TUMOR VOLUME;

EID: 73149092981     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22109     Document Type: Article

References (22)

1. Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, Dahmen G, Bockisch A, Debatin JF, Ruehm SG. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 2003;290:3199-3206.
2. Brennan DD, Gleeson T, Coate LE, Cronin C, Carney D, Eustace SJ. A comparison of whole-body MRI and CT for the staging of lymphoma. AJR Am J Roentgenol 2005;185:711-716.
3. Goo HW, Choi SH, Ghim T, Moon HN, Seo JJ. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods. Pediatr Radiol 2005;35:766-773.
4. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22:275-282.
5. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43: 828-836.
6. Komori T, Narabayashi I, Matsumura K, Matsuki M, Akagi H, Ogura Y, Aga F, Adachi I. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med 2007;21:209-215.
7. Li S, Sun F, Jin ZY, Xue HD, Li ML. Whole-body diffusion-weighted imaging: technical improvement and preliminary results. J Magn Reson Imaging 2007;26:1139-1144.
8. Nakanishi K, Kobayashi M, Nakaguchi K, Kyakuno M, Hashimoto N, Onishi H, Maeda N, Nakata S, Kuwabara M, Murakami T, Nakamura H. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn Reson Med Sci 2007;6: 147-155.
9. Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, Matsumoto S, Kotani Y, Sugimura K. Non-small cell lung cancer: whole-body MR examination for M-stage assessment: utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/ CT. Radiology 2008;248:643-654.
10. Cline HE, Lorensen WE, Kikinis R, Jolesz F. Three-dimensional segmentation of MR images of the head using probability and connectivity. J Comput Assist Tomogr 1990;14:1037-1045.
11. Vannier MW, Butterfield RL, Jordan D, Murphy WA, Levitt RG, Gado M. Multispectral analysis of magnetic resonance images. Radiology 1985;154:221-224.
12. Carano RA, Ross AL, Ross J, Williams SP, Koeppen H, Schwall RH, Van Bruggen N. Quantification of tumor tissue populations by multispectral analysis. Magn Reson Med 2004;51:542-551.
13. Henning EC, Azuma C, Sotak CH, Helmer KG. Multispectral quantification of tissue types in a RIF-1 tumor model with histological validation. Part I. Magn Reson Med 2007;57:501-512.
14. Tou JT, Gonzales RC. Pattern recognition principles. Reading, MA: Addison-Wesley; 1974. 377 p.
15. Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992;52:1399-1405.
16. Mori S, van Zijl PC. A motion correction scheme by twin-echo navigation for diffusion-weighted magnetic resonance imaging with multiple RF echo acquisition. Magn Reson Med 1998;40:511-516.
17. Duda RO, Hart PE. Pattern classification and scene analysis. New York, NY: John Wiley & Sons; 1973. 482 p.
18. DuPre SA, Hunter KW Jr. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp Mol Pathol 2007;82:12-24.
19. Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 2008;8:228.
20. O'Keane JC, Wolf BC, Neiman RS. The pathogenesis of splenic extramedullary hematopoiesis in metastatic carcinoma. Cancer 1989;63: 1539-1543.
21. Trouard TP, Theilmann RJ, Altbach MI, Gmitro AF. High-resolution diffusion imaging with DIFRAD-FSE (diffusion-weighted radial acquisition of data with fast spin-echo) MRI. Magn Reson Med 1999;42:11-18.
22. Stadlbauer A, Ganslandt O, Buslei R, Hammen T, Gruber S, Moser E, Buchfelder M, Salomonowitz E, Nimsky C. Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology 2006;240:803-810.